Ambar Protein schedules board meet on May 30 for Q4FY26 results

1 min read     Updated on 20 May 2026, 01:45 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Ambar Protein Industries Limited will hold a board meeting on May 30, 2026, to approve audited financial results for the quarter and year ended March 31, 2026. The agenda includes reviewing related party transactions with M/s. Ankur Oil Industries. The trading window for insiders has been closed from April 1, 2026, until 48 hours post-result announcement.

powered bylight_fuzz_icon
40810524

*this image is generated using AI for illustrative purposes only.

Ambar Protein Industries Limited has announced that its board of directors will meet on May 30, 2026, to discuss and approve the audited financial results for the quarter and fiscal year ending March 31, 2026. The meeting is scheduled to take place at 03:30 PM at the company's registered office located on the Sarkhej - Bavla Highway in Ahmedabad.

Agenda for the Meeting

The primary focus of the board meeting will be the financial performance of the company for the fourth quarter and the full financial year 2026. Alongside the financial results, the directors will consider specific related party transactions involving M/s. Ankur Oil Industries. The board will also transact other routine business items as listed on the agenda.

Trading Window Closure

In compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct, the trading window for dealing in the company's shares has been closed. This restriction applies to all designated employees and insiders. The closure period commenced on April 1, 2026, and will remain in effect until 48 hours after the financial results information is made generally available to the public.

Meeting Details

The following table summarizes the key details regarding the upcoming board meeting:

Event Details Information
Meeting Date May 30, 2026
Meeting Time 03:30 PM
Venue Registered Office, Sarkhej - Bavla Highway, Ahmedabad
Financial Period Quarter and Year ended March 31, 2026
Trading Window Closure April 1, 2026 onwards

Historical Stock Returns for Ambar Protein Industries

1 Day5 Days1 Month6 Months1 Year5 Years
+7.59%+5.72%+11.77%-30.17%-1.50%+2,580.27%

How might Ambar Protein Industries' FY2026 financial results compare to industry peers in the protein/edible oil sector, and what growth trajectory could investors expect going forward?

What are the potential implications of the related party transactions with M/s. Ankur Oil Industries on Ambar Protein Industries' future profitability and corporate governance standing?

Could the board meeting on May 30, 2026 also serve as a platform to announce dividend declarations or capital allocation strategies for the upcoming fiscal year?

Ambar Protein Industries
View Company Insights
View All News
like15
dislike

Ambar Protein Industries Submits Quarterly Compliance Certificate for Q4FY26 to BSE

1 min read     Updated on 09 Apr 2026, 04:00 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Ambar Protein Industries Limited submitted its Q4FY26 compliance certificate to BSE under SEBI Regulation 74(5), confirming proper handling of dematerialized securities. The certificate, provided by registrar MUFG Intime India Private Limited, validates that all securities received for dematerialization during the quarter ended 31st March 2026 were appropriately processed and listed on relevant exchanges. This regulatory filing demonstrates the company's commitment to maintaining compliance with SEBI's depository regulations and ensuring transparent securities handling procedures.

powered bylight_fuzz_icon
37276213

*this image is generated using AI for illustrative purposes only.

Ambar protein industries Limited has submitted its quarterly compliance certificate to BSE for the quarter ended 31st March 2026, fulfilling regulatory requirements under SEBI's depository regulations. The submission, dated 09th April 2026, addresses the company's compliance with securities handling procedures during Q4FY26.

Regulatory Compliance Certificate

The certificate was issued under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018. This regulation mandates companies to provide confirmation regarding the proper handling of securities received for dematerialization during each quarter.

Parameter: Details
Reporting Quarter: Q4FY26 (ended 31st March 2026)
Submission Date: 09th April 2026
Regulation: SEBI Regulation 74(5)
Scrip Code: 519471
Registrar: MUFG Intime India Private Limited

Registrar Confirmation

MUFG Intime India Private Limited, formerly Link Intime India Private Limited, serves as the company's registrar and share transfer agent. The registrar provided comprehensive confirmation dated 01st April 2026 regarding securities handling during the quarter.

The registrar confirmed several key compliance aspects:

  • Securities received from depository participants for dematerialization were properly confirmed to depositories
  • All securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed
  • Security certificates received for dematerialization were appropriately confirmed or rejected
  • Received certificates were mutilated and cancelled after due verification by depository participants
  • Depository names were substituted in the register of members as registered owners within prescribed timelines

Company Information

Ambar Protein Industries Limited operates from its facility located at Plot No. 351, 353, 358, opposite Bhagyoday Hotel, Sarkhej-Bavla Highway, Changodar, Ta. Sanand, Dist. Ahmedabad, Gujarat. The company maintains its corporate identification number as L15400GJ1992PLC018758 and operates under Ahmedabad jurisdiction.

Regulatory Significance

This quarterly compliance certificate demonstrates the company's adherence to SEBI's depository regulations, ensuring transparency in securities handling and maintaining investor confidence. The timely submission reflects proper corporate governance practices and regulatory compliance management by the company's compliance officer.

Historical Stock Returns for Ambar Protein Industries

1 Day5 Days1 Month6 Months1 Year5 Years
+7.59%+5.72%+11.77%-30.17%-1.50%+2,580.27%

Will Ambar Protein Industries' consistent regulatory compliance help attract institutional investors in FY27?

How might the company's partnership with MUFG Intime India impact its future share transfer efficiency and investor services?

Could Ambar Protein Industries be planning any corporate actions or equity fundraising given their focus on securities handling compliance?

Ambar Protein Industries
View Company Insights
View All News
like16
dislike

More News on Ambar Protein Industries

1 Year Returns:-1.50%